Folgen
Andreas Henri Diacon
Andreas Henri Diacon
Bestätigte E-Mail-Adresse bei sun.ac.za
Titel
Zitiert von
Zitiert von
Jahr
The diarylquinoline TMC207 for multidrug-resistant tuberculosis
AH Diacon, A Pym, M Grobusch, R Patientia, R Rustomjee, L Page-Shipp, ...
New England Journal of Medicine 360 (23), 2397-2405, 2009
9342009
Multidrug-resistant tuberculosis and culture conversion with bedaquiline
AH Diacon, A Pym, MP Grobusch, JM de los Rios, E Gotuzzo, I Vasilyeva, ...
New England Journal of Medicine 371 (8), 723-732, 2014
6892014
14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
AH Diacon, R Dawson, F von Groote-Bidlingmaier, G Symons, A Venter, ...
The Lancet 380 (9846), 986-993, 2012
4902012
Diagnostic tools in tuberculous pleurisy: a direct comparative study
AH Diacon, BW Van de Wal, C Wyser, JP Smedema, J Bezuidenhout, ...
European Respiratory Journal 22 (4), 589-591, 2003
4732003
Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug …
AH Diacon, PR Donald, A Pym, M Grobusch, RF Patientia, R Mahanyele, ...
Antimicrobial agents and chemotherapy 56 (6), 3271-3276, 2012
4272012
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis
R Rustomjee, AH Diacon, J Allen, A Venter, C Reddy, RF Patientia, ...
Antimicrobial agents and chemotherapy 52 (8), 2831-2835, 2008
3322008
Accuracy of pleural puncture sites: a prospective comparison of clinical examination with ultrasound
AH Diacon, MH Brutsche, M Soler
Chest 123 (2), 436-441, 2003
3262003
Treatment of highly drug-resistant pulmonary tuberculosis
F Conradie, AH Diacon, N Ngubane, P Howell, D Everitt, AM Crook, ...
New England Journal of Medicine 382 (10), 893-902, 2020
3092020
Bedaquiline in the treatment of multidrug-and extensively drug-resistant tuberculosis
AS Pym, AH Diacon, SJ Tang, F Conradie, M Danilovits, C Chuchottaworn, ...
European Respiratory Journal 47 (2), 564-574, 2016
2912016
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, ...
New England Journal of Medicine 379 (17), 1621-1634, 2018
2902018
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ...
The Lancet infectious diseases 17 (1), 39-49, 2017
2862017
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
MJ Boeree, AH Diacon, R Dawson, K Narunsky, J Du Bois, A Venter, ...
American journal of respiratory and critical care medicine 191 (9), 1058-1065, 2015
2732015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label …
R Dawson, AH Diacon, D Everitt, C van Niekerk, PR Donald, DA Burger, ...
The Lancet 385 (9979), 1738-1747, 2015
2542015
Intrapleural streptokinase for empyema and complicated parapneumonic effusions
AH Diacon, J Theron, MM Schuurmans, BW Van de Wal, CT Bolliger
American journal of respiratory and critical care medicine 170 (1), 49-53, 2004
2522004
Why do we use 600 mg of rifampicin in tuberculosis treatment?
J Van Ingen, RE Aarnoutse, PR Donald, AH Diacon, R Dawson, ...
Clinical Infectious Diseases 52 (9), e194-e199, 2011
2422011
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis
DR Tait, M Hatherill, O Van Der Meeren, AM Ginsberg, E Van Brakel, ...
New England Journal of Medicine 381 (25), 2429-2439, 2019
2362019
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
AH Diacon, R Dawson, M Hanekom, K Narunsky, A Venter, N Hittel, ...
The International journal of tuberculosis and lung disease 15 (7), 949-954, 2011
2322011
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
AH Diacon, RF Patientia, A Venter, PD Van Helden, PJ Smith, H McIlleron, ...
Antimicrobial agents and chemotherapy 51 (8), 2994-2996, 2007
2032007
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
JM Bryant, SR Harris, J Parkhill, R Dawson, AH Diacon, P van Helden, ...
The Lancet Respiratory Medicine 1 (10), 786-792, 2013
1962013
Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients
AH Diacon, R Dawson, M Hanekom, K Narunsky, SJ Maritz, A Venter, ...
Antimicrobial agents and chemotherapy 54 (8), 3402-3407, 2010
1962010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20